VIDEO: OncoSec Medical, Inc. (ONCS)

OncoSec Medical Incorporated, a biotechnology company, designs, develops, and commercializes gene therapies, and therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer in the United States. Its lead program, ImmunoPulse IL-12, is in Phase II development for various indications, including metastatic melanoma, squamous cell carcinoma of the head and neck, and triple-negative breast cancer. ImmunoPulse is an electroporation delivery device used in combination with the company’s therapeutic product candidates, including DNA plasmids that encode for immunologically active agents, and to deliver the therapeutic directly into the tumor and promote an inflammatory response against the cancer.


BLOG COMMENTS POWERED BY DISQUS

Small Cap Movers

DIEGO PELLICER WORLDWIDE INC

PNK : DPWW - 11 Jul, 2:13pm
0.65
+0.00 (+0.00%) After Hours:
Open Mktcap 24.57M
High 52wk Hight
Low 52wk Low
Vol 0 Avg Vol
Eps P/e
Currency: USD

BIO-KEY INTL INC

PNK : BKYI - 12 Jul, 3:48pm
0.2205
-0.0180 (-7.5472%) After Hours:
Open 0.2000 Mktcap 14.63M
High 0.2399 52wk Hight 0.3100
Low 0.2000 52wk Low 0.1000
Vol 36150 Avg Vol 131438
Eps P/e
Currency: USD

Chanticleer Holdings, Inc.

NCM : HOTR - 12 Jul, 4:00pm
0.495
+0.045 (+10.000%) After Hours:
Open 0.480 Mktcap 10.56M
High 0.620 52wk Hight 2.730
Low 0.433 52wk Low 0.410
Vol 855941 Avg Vol 74903
Eps -0.270 P/e
Currency: USD

NanoViricides, Inc. NEW Common

ASE : NNVC - 12 Jul, 4:00pm
1.69
-0.05 (-2.87%) After Hours:
Open 1.73 Mktcap 97.97M
High 1.75 52wk Hight 3.44
Low 1.68 52wk Low 0.89
Vol 81632 Avg Vol 146763
Eps -0.20 P/e
Currency: USD